Daniel E. Weiner, MD, a nephrologist at Tufts Medical Center and associate professor of medicine at Tufts University School of Medicine in Boston, Massachusetts, received the National Kidney Foundation’s top research award at the 2022 Spring Clinical Meetings.
Creatinine alone does not reliably predict renal decline in the AKPKD population, according to investigators.
Patients with vs without chronic kidney disease have 32% lower odds of undergoing invasive cardiac procedures for acute coronary syndrome in adjusted analyses.
Hyper- and hyponatremia in patients with kidney failure are significantly associated with a 2.0- and 1.8-fold increased risk of dying in the hospital, respectively.
The federal Comprehensive ESRD Care initiative “may incentivize treatment patterns that generate short-term savings but may be costlier long-term,” according to investigators.
Nearly 24% of patients with advanced CKD, including those on dialysis, have gout, according to a study.
Policy-level interventions targeting underserved populations are necessary to improve their access to care.
Investigators report sustained reductions in urinary and plasma oxalate through 24 months of lumasiran treatment.
In a study of patients with CKD and/or heart failure on RAASi therapy, the proportion of patients who received dose reductions or had therapy discontinued after new-onset hyperkalemia increased with hyperkalemia severity.
Nearly two-thirds of patients receiving dialysis use phosphate binders intermittently, a study found.
